The article entitled “Drug Makers, in Shift, Join Fight Against Doping” which was written by Katie Thomas and published online in The New York Times presented relevant issues pertaining to drugs that were apparently abused by athletes, particularly that which was revealed by Lance Armstrong. The focus was on blood-enhancing drug, known as EPO, which allegedly were abused by cyclists. In this regard, other drug manufacturers such as GlaxoSmithKline and Roche, manifested support for current thrusts of officials from international anti-doping agencies to intensify their efforts in detecting athletes’ rampant use of illegal drugs through more stringent tests. Thus, the people and organizations that were specifically noted in the article included these drug manufacturers, officials of anti-doping organizations, and reference to athletes, particularly Lance Armstrong and other top cyclists, who were noted to have abused this kind of performance enhancing drug. Initially, the revelation of Lance Armstrong could have provided the impetus for the subsequent more and could have initiated some form of sensationalism.
However, as a whole, the story is actually objective and newsworthy in terms of manifesting commitment by all concerned group, from the manufacturers to international sports officials, to address the problem faced as athletes continue to determine new drugs that could apparently enhance their performance; and therefore, give them unfair advantage over other athletes. If left unabated, international sports would continue to be besieged with problems on performance drugs and could seriously jeopardize their universal credibility. The reported move proved to be a much needed course of action, as it would be serving the best interests of all athletes and the general public who expect non-partiality, professionalism, as well as fair and just treatment for all sports participants and enthusiasts. For more information, the post to the story could be found through this link: http://www.nytimes.com/2013/02/19/business/drug-makers-increasingly-join-fight-against-doping.html?_r=0.
Work Cited
Thomas, Katie. "Drug Makers, in Shift, Join Fight Against Doping." 18 February 2013. The New York Times. 22 February 2013
